ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Viventia Biotech Inc. Delisted | — | Canada | — | 60 |
| ALPHA BETA TECHNOLOGY INC Delisted | — | United States of America | — | 58 |
| Avalyn Pharma Inc. | AVLN | United States of America | — | 58 |
| Generate Biomedicines, Inc. | GENB | United States of America | — | 58 |
| GENOMED INC Delisted | — | United States of America | — | 57 |
| SUGEN INC Delisted | — | United States of America | — | 57 |
| Conexeu Sciences Inc. | CNXU | United States of America | — | 56 |
| CRESCENDO PHARMACEUTICALS CORP Delisted | — | United States of America | — | 56 |
| Eikon Therapeutics, Inc. | EIKN | United States of America | — | 56 |
| Kardigan, Inc. Common Stock | KARD | United States of America | — | 55 |
| Seaport Therapeutics, Inc. | SPTX | United States of America | — | 55 |
| AMERIMMUNE PHARMACEUTICALS INC Delisted | — | United States of America | — | 54 |
| PILOT THERAPEUTICS HOLDINGS INC Delisted | — | United States of America | — | 54 |
| SPARTA PHARMACEUTICALS INC Delisted | — | United States of America | — | 54 |
| Verseon Corporation Delisted | — | United Kingdom | — | 54 |
| Sunhawk Vision Biotech, Inc. | 7759 | Taiwan | — | 53 |
| Genesis Research and Development Corporation Limited Delisted | GEN | New Zealand | — | 52 |
| Parabilis Medicines, Inc. | PBLS | United States of America | — | 52 |
| Hemab Therapeutics Holdings, Inc. | COAG | United States of America | — | 51 |
| Antibe Therapeutics Inc. Delisted | ATE | Canada | — | 50 |
| Kanaph Therapeutics Inc. | 0082N0 | South Korea | — | 50 |
| AgomAb Therapeutics NV American Depositary Shares | AGMB | United States of America | — | 48 |
| Anbogen Therapeutics, Inc. | 7784 | Taiwan | — | 48 |
| U-Neuron Biomedical Inc. | 6973 | Taiwan | — | 48 |
| Attovia Therapeutics, Inc. | — | United States of America | — | 47 |
| GENEMEDICINE INC Delisted | — | United States of America | — | 46 |
| ORAVAX INC Delisted | — | United States of America | — | 46 |
| COMBICHEM INC Delisted | — | United States of America | — | 45 |
| Curasight A/S | CURAS | Denmark | — | 45 |
| NEUREX CORP Delisted | — | United States of America | — | 44 |
| Pharmasaga Company Limited | 7878 | Taiwan | — | 44 |
| Aimed Bio Inc. | 0009K0 | South Korea | — | 43 |
| Braveheart Bio, Inc. | — | United States of America | — | 43 |
| Rznomics Inc. | 476830 | South Korea | — | 43 |
| LongBio Pharma (Suzhou) Co., Ltd. | — | Hong Kong | — | 42 |
| ANYA BIOPHARM INC. | 7776 | Taiwan | — | 41 |
| Celltech Group Delisted | — | United Kingdom | — | 41 |
| DEMEGEN INC Delisted | — | United States of America | — | 41 |
| EVOPOINT BIOSCIENCES CO., LTD. | 688837 | China | — | 41 |
| Veraxa Biotech AG Ordinary Shares | VRXA | Switzerland | — | 41 |
| Ribi Immunochem Research Inc Delisted | RIBI | United States of America | — | 40 |
| CISTRON BIOTECHNOLOGY INC Delisted | — | United States of America | — | 38 |
| QuadMedicine Inc. | 464490 | South Korea | — | 38 |
| Transcend Therapeutics Inc Delisted | TSND | United States of America | — | 38 |
| Vaxart Inc | VXRT | United States of America | — | 38 |
| Dasher Neuroscience Holdings Inc. | 7829 | Taiwan | — | 37 |
| OBIGEN PHARMA, INC. | 7876 | Taiwan | — | 37 |
| Scribe Therapeutics, Inc. | — | United States of America | — | 37 |
| TenNor Therapeutics (Suzhou) Limited | — | Hong Kong | — | 37 |
| BlossomHill Therapeutics, Inc. | — | United States of America | — | 36 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.